Exosomes and Angiogenesis: A Cutting-Edge Frontier in Life Science Research
Exosomes are nanoscale extracellular vesicles that can be secreted by almost all types of cells, including tumor cells, macrophages, neurons, endothelial progenitor cells, dendritic cells, and bone marrow mesenchymal stem cells. They are present in various body fluids such as whole blood, plasma, urine, cerebrospinal fluid, saliva, breast milk, and tears. Exosomes possess typical characteristics of donor cells, and their contents include proteins, lipids, genetic materials, and small-molecule metabolites. Among them, mature miRNAs account for nearly 41.7% of the total RNA in exosomes and play a crucial role in the functional exertion of exosomes.
These characteristics endow exosomes with excellent biological properties, including biocompatibility, stability, low toxicity, low immunogenicity, and efficient exchange of molecular cargo. These advantages make exosomes promising candidates in regenerative medicine and tissue engineering. Particularly, their role in angiogenesis has been verified in various cell types, thus exhibiting broad application prospects in ischemic diseases.
The isolation and purification of exosomes are key issues and challenges for researchers, so obtaining high-purity exosomes is critical for scientific research. Relevant technical points are as follows: 1. Enrichment method: Ultracentrifugation is the most widely used technique for isolating exosomes from cell culture supernatants. 2. Preservation method: After extraction, exosomes are generally suspended in phosphate-buffered saline (PBS). Current preservation technologies mainly include freezing, freeze-drying, and spray-drying. It is recommended to use fresh exosomes immediately after extraction or store them at low temperatures for a short period. They can be stored at 4°C or -20°C for a short time, and at -80°C for long-term storage, but repeated freeze-thaw cycles should be avoided. 3. Identification methods: Transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot are the three commonly used characterization methods. 4. Mechanism exploration: Exosome tracing technology is widely used, and tracing exosomes with lipophilic fluorescent dyes is simple to operate and has been widely applied.
Angiogenesis refers to the physiological process by which a new microvascular system develops into a blood supply system. It is a multi-step and highly regulated process that is crucial for growth, development, and the repair of damaged tissues. Angiogenesis can occur through two mechanisms: sprouting and non-sprouting. It is controlled by various growth factors and signaling pathways, and its occurrence depends on the balance between pro-angiogenic factors and anti-angiogenic factors in the biological environment.
A large number of studies have shown that the occurrence of malignant tumors is accompanied by a high level of angiogenesis. Angiogenic factors such as VEGF, Ang-2, FGF, TGF-β, HGF, and ET bind to their corresponding receptors to activate related signaling pathways. The glycolytic pathway of endothelial cells (ECs) promotes the migration of tumor cells (TCs) and the proliferation of stem cells (SCs). The activation of signaling pathways such as DLL4 and PDGF stimulates vascular branching and maturation.
Therefore, appropriate targets can be selected for tumor-targeted therapy based on angiogenesis-related signaling pathways. The macromolecular monoclonal antibody drug bevacizumab can bind to VEGF, preventing its signal transduction with VEGFR receptors, thereby exerting an anti-angiogenic effect. Small-molecule multi-target tyrosine kinase inhibitors block angiogenesis by inhibiting receptor signaling pathways. Recombinant human endostatin inhibits the migration of ECs and prevents angiogenesis.
Since the "regulation mechanism of cellular vesicular transport" was awarded the Nobel Prize in Physiology or Medicine in 2013, exosomes, as one of the extracellular vesicles, have gradually become a research hotspot among domestic and foreign researchers. In recent years, the research on the interaction between exosomes and angiogenesis has made remarkable progress, becoming a frontier direction in the field of life sciences, especially in the research of ischemic diseases and malignant tumors.
In the field of ischemic diseases, a large number of studies have reported that exosomes from different sources can repair vascular damage and promote angiogenesis in various ischemic disease models, thereby delaying the pathological process of angiogenesis disorders. In the field of tumors, the regulation of exosomes on tumor angiogenesis and tumor cell ferroptosis has become a new research direction. For example, a study published in Signal Transduction and Targeted Therapy (IF=38) first revealed that myocardial infarction (MI) inhibits Erastin-induced ferroptosis by releasing exosomes enriched with miR-22-3p derived from cardiomyocytes, suggesting that targeting exosome-mediated pathological communication between cardiomyocytes and tumors may provide a new approach for ferroptosis-based anti-tumor therapy.
In addition, the exploration of miRNA-mediated regulatory mechanisms between exosomes and angiogenesis is also a current research focus. A review paper published in the Chinese Journal of Pathophysiology summarizes the role and regulatory mechanisms of exosomes from different stem cells (such as bone marrow mesenchymal stem cells, adipose stem cells, human umbilical cord mesenchymal stem cells, etc.) in angiogenesis, emphasizing the miRNA-mediated mechanisms. With the continuous development of technologies such as exosome separation and purification, tracing, and molecular detection, the research on exosomes and angiogenesis is moving towards a more precise and in-depth direction, and the clinical transformation potential is increasingly prominent.
The research on exosomes and angiogenesis has important theoretical and practical significance in the field of life sciences and medicine. Theoretically, in-depth exploration of the interaction mechanism between exosomes and angiogenesis helps to clarify the regulatory network of angiogenesis, enrich the understanding of the physiological and pathological processes of vascular development and repair, and provide new theoretical support for the study of related diseases.
Practically, this research provides new ideas and targets for the diagnosis and treatment of angiogenesis-related diseases. In ischemic diseases (such as myocardial infarction, cerebral infarction, etc.), exosomes can be used as potential therapeutic vectors or drugs to promote angiogenesis and repair damaged tissues, which has important clinical application value. In tumor therapy, targeting the regulatory pathway of exosomes on tumor angiogenesis can develop new anti-tumor strategies, improving the efficacy of tumor treatment. In addition, exosomes in body fluids can also be used as potential biomarkers for the diagnosis and prognosis evaluation of angiogenesis-related diseases, providing a new basis for clinical precision medicine.
4. Related Mechanisms, Research Methods and Product Applications
The regulatory mechanism of exosomes on angiogenesis is complex, among which the miRNA-mediated mechanism is the most widely studied. Exosomes carry specific miRNAs derived from donor cells, which are transported to target cells through exosomes. These miRNAs regulate the expression of target genes in target cells by binding to the 3'-untranslated region (3'-UTR) of target mRNAs, thereby affecting the proliferation, migration, and tube formation of endothelial cells, and ultimately regulating angiogenesis. For example, exosomes derived from stem cells can deliver pro-angiogenic miRNAs to endothelial cells, activating angiogenesis-related signaling pathways and promoting angiogenesis.
In addition, exosomes can also regulate angiogenesis by transporting proteins and lipids. The proteins (such as growth factors, cytokines) and lipids in exosomes can directly bind to receptors on the surface of target cells, activating downstream signaling pathways, or participate in the formation and function of cell membranes, thereby regulating the biological behavior of target cells and affecting angiogenesis.
The research on exosomes and angiogenesis involves multiple technical links, including exosome isolation and purification, identification, tracing, and functional verification of angiogenesis. 1. Exosome isolation and purification: Ultracentrifugation is the gold standard method, and exosome extraction kits can also be used for efficient extraction, which is more convenient and fast. 2. Exosome identification: A combination of transmission electron microscopy (morphological identification), nanoparticle tracking analysis (particle size and concentration detection), and Western blot (detection of specific markers such as CD63, CD81) is used to ensure the purity and authenticity of exosomes. 3. Exosome tracing: Lipophilic fluorescent dyes (such as DiD, DiR, DiO, DiI) are used to label exosomes, and then the uptake and transport of exosomes by target cells are observed under a fluorescent microscope, which helps to clarify the interaction between exosomes and target cells. 4. Angiogenesis functional verification: In vitro experiments include endothelial cell proliferation assay, migration assay, and tube formation assay; in vivo experiments include mouse Matrigel plug assay, chick chorioallantoic membrane (CAM) assay, etc., to verify the regulatory effect of exosomes on angiogenesis.
ANT BIO PTE. LTD. provides a full range of high-quality products for the research on exosomes and angiogenesis, covering exosome extraction, nucleic acid extraction, culture, lysis, and angiogenesis small-molecule compounds, which can meet the diverse needs of researchers. Specific product applications are as follows:
1. Exosome research-related products: The Plasma/Serum Exosome Extraction Kit (abs50039) and Cell Supernatant Exosome Extraction Kit (abs50040) can efficiently extract high-purity exosomes from different samples, with simple operation and stable results, suitable for the initial isolation of exosomes. The Exosome RNA Extraction Kit (abs60263) and Exosome DNA Extraction Kit (abs60364) can effectively extract nucleic acids (RNA/DNA) from exosomes, providing high-quality samples for subsequent molecular biology experiments such as miRNA detection. The Exosome-Specific Serum-Free Medium (abs9430) provides a suitable culture environment for cell secretion of exosomes, avoiding the interference of exosomes in serum. The Exosome-Specific Lysis Buffer (abs9587) can fully lyse exosomes and release their internal contents for subsequent protein or nucleic acid detection. The Exosome-Depleted Fetal Bovine Serum (abs993) eliminates the interference of exogenous exosomes in serum, ensuring the accuracy of experimental results.
2. Angiogenesis small-molecule compounds: ANT BIO PTE. LTD. provides a variety of angiogenesis-related small-molecule compounds, including inhibitors of VEGF, PDGF, and other signaling pathways. For example, Nintedanib (abs810506), Lenvatinib (abs810651), Regorafenib (abs810672), Sorafenib Tosylate (abs810719), Axitinib (abs813181), etc., can be used to study the regulatory mechanism of angiogenesis-related signaling pathways and develop tumor-targeted therapy strategies. These compounds have high purity and stable activity, ensuring the reliability of experimental results.
3. Lipophilic fluorescent dyes for exosome tracing: The lipophilic fluorescent dyes provided by ANT BIO PTE. LTD., such as DiD p-Chlorobenzenesulfonate (abs47048165), DiR Iodide (abs45153692), DiO Perchlorate (abs45153674), and DiI Perchlorate (abs42002237), have the advantages of high fluorescence intensity and good stability. They can specifically label exosomes, facilitating the observation of exosome transport and uptake by target cells, and providing powerful tools for the study of exosome-mediated intercellular communication.
ANT BIO PTE. LTD. is committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. We deeply recognize the important value of exosome and angiogenesis research in promoting the development of life sciences and medicine, and have been dedicated to providing researchers with high-performance products and professional technical support. Our professional R&D team continuously optimizes product performance to meet the increasingly sophisticated experimental needs. The strict quality control system ensures that each batch of products has stable quality and reliable performance. With our specialized sub-brands (Absin, Starter, UA), we cover a full spectrum of research needs from general reagents and kits to antibodies and recombinant proteins. We strive to be a trusted partner for researchers worldwide, providing powerful support for unlocking scientific mysteries, promoting medical progress, and realizing the clinical transformation of scientific research achievements.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
